Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 31, 2019 - Issue 1
169
Views
1
CrossRef citations to date
0
Altmetric
Articles

Contextual compatibility of three empirically supported behavior therapies for cART adherence among patients with substance use disorders

, &
Pages 19-24 | Received 08 Mar 2018, Accepted 26 Oct 2018, Published online: 16 Nov 2018

References

  • Aarons, G. A. (2006). Tranformational and transactional leadership: Association with attitudes toward evidence-based practice. Psychiatric Services, 57, 1162–1169. doi: 10.1176/ps.2006.57.8.1162
  • Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet, 376(9738), 367–387. doi: 10.1016/S0140-6736(10)60829-X
  • Beck, A. T., Wright, F. D., Newman, C. F., & Liese, B. S. (1993). Cognitive therapy of substance abuse. New York, NY: Guilford Press.
  • Bernard, H. S., & Ryan, G. W. (2010). Analyzing qualitative data: Systematic approaches. Los Angelos, CA: Sage Publications, Inc.
  • Camp Binford, M., Kahana, S. Y., & Altice, F. L. (2012). A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Current HIV/AIDS Reports, 9(4), 287–312. doi: 10.1007/s11904-012-0134-8
  • Hartzler, B., Dombrowski, J. C., Crane, H. M., Eron Jr., J. J., Geng, E. H., Mathews, W. C., … Donovan, D. M. (2017). Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS and Behavior, 21(4), 1138–1148. doi: 10.1007/s10461-016-1584-6
  • Higgins, S. T., Silverman, K., & Heil, S. H. (2008). Contingency management in substance abuse treatment. New York, NY: Guilford.
  • Lima, V. D., Harrigan, R., Bangsberg, D. R., Hogg, R. S., Gross, R., Yip, B., & Montaner, J. S. (2009). The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. JAIDS, 50(5), 529–536.
  • Madson, M. B., Loignon, A. C., & Lane, C. (2009). Training in motivational interviewing: A systematic review. Journal of Substance Abuse Treatment, 36, 101–109. doi: 10.1016/j.jsat.2008.05.005
  • McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., … Argeriou, M. (1992). The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment, 9, 199–213. doi: 10.1016/0740-5472(92)90062-S
  • Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change. New York, NY: Guilford.
  • Miller, W. R., Yahne, C. E., Moyers, T. B., Martinez, J., & Pirritano, M. (2004). A randomized trial of methods to help clinicians learn motivational interviewing. Journal of Counseling and Clinical Psychology, 72(6), 1050–1062. doi: 10.1037/0022-006X.72.6.1050
  • Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G. A., Bunger, A., … Hensley, M. (2011). Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health and Mental Health Services Research, 38(2), 65–76. doi: 10.1007/s10488-010-0319-7
  • Rollnick, S., Miller, W. R., & Butler, C. C. (2008). Motivational interviewing in healthcare: Helping patients change behavior. New York, NY: The Guilford Press.
  • Roux, P., Carrieri, M. P., Cohen, J., Ravaux, I., Poizot-Martin, I., Dellamonica, P., & Spire, B. (2009). Retention in opioid substitution treatment: A major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clinical Infectious Diseases, 49(9), 1433–1440. doi: 10.1086/630209
  • Sandelowski, M. (1995). Sample size in qualitative research. Research in Nursing and Health, 18, 179–183. doi: 10.1002/nur.4770180211
  • Schwalbe, C. S., Oh, H. Y., & Zweben, A. (2014). Sustaining motivational interviewing: A meta-analysis. Addiction, 109, 1287–1294. doi: 10.1111/add.12558
  • Volkow, N. D., Baler, R. D., & Normand, J. L. (2011). The unrealized potential of addiction science in curbing the HIV epidemic. Current HIV Research, 9, 393–395. doi: 10.2174/157016211798038605
  • Werb, D., Mills, E. J., Montaner, J. S., & Wood, E. (2010). Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: A meta-analysis. Lancet Infectious Diseases, 10, 464–469. doi: 10.1016/S1473-3099(10)70097-9
  • Wood, E., Hogg, R. S., Lima, V. D., Kerr, T., Yip, B., Marshall, B. D. L., & Montaner, J. S. (2008). Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA, 300(5), 550–554. doi: 10.1001/jama.300.5.550
  • Wood, E., Hogg, R. S., Yip, B., Dong, W. W., Wynhoven, B., Mo, T., … Harrigan, P. R. (2005). Rates of antiretorviral resistance among HIV-infected patients with and without a history of injection drug use. Aids (london, England), 19(11), 1189–1195. doi: 10.1097/01.aids.0000176219.48484.f1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.